Bad Science
Sarepta, eteplirsen: anecdote, data, surrogate outcomes, and the FDA
The Duchenne’s treatment made by Sarepta (eteplirsen) has been in the news this week, as a troubling example of the FDA ...(read more)
by Ben Goldacre
Aggregating the best of the blogs on science and pseudoscience
September 30, 2016
September 28, 2016
Bad Science
The Cancer Drugs Fund is producing dangerous, bad data: randomise everyone, everywhere!
There are recurring howls in my work. One of them is this: in general, if you don’t know which intervention works best, then ...(read more)
by Ben Goldacre
September 23, 2016
Bad Science
Taking transparency beyond results: ethics committees must work in the open
Here’s a useful paper we’ve just published in the BMJ, documenting problems in transparency around approval processes for randomised trials. There’s ...(read more)
by Ben Goldacre
Bad Science
Events in Sydney, Melbourne, Brisbane, Auckland
Hi there, I’m doing a few events in Australia and NZ this week: in Sydney, Melbourne, Auckland (only 25 tickets ...(read more)
by Ben Goldacre